Oxazaphosphorine
WebCyclophosphamide ( CP ), also known as cytophosphane among other names, [3] is a medication used as chemotherapy and to suppress the immune system. [4] As chemotherapy it is used to treat lymphoma, multiple myeloma, leukemia, ovarian cancer, breast cancer, small cell lung cancer, neuroblastoma, and sarcoma. [4] WebTetrahydro-2-(bis(2-chloroethyl)amino)-3-methyl-2H-1,3,2-oxazaphosphorine 2-oxide C8H17Cl2N2O2P CID 211031 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and more.
Oxazaphosphorine
Did you know?
WebThe oxazaphosphorine cyclophosphamide is one of the most widely used drugs in cancer chemotherapy. It is also used as an immunosuppressive at lower doses. As with the other anticancer drugs discussed in previous sessions, it is a prodrug. Webother oxazaphosphorine cytostatics like Ifosfamide (IF). The enzymatic cleavage of ALDO to form PAM and HPA is important for another reason that makes CP exceptional as an alkylating cytostatic. HPA - which becomes acrolein by elimination of water - is a pro-apoptotic aldehyde that promotes apoptosis by inhibiting the anti-
WebOxazaphosphorine C3H4NOP CID 22137869 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, safety/hazards/toxicity information, supplier lists, and … WebApr 1, 2015 · For intermittent oxazaphosphorine therapy following an initial intravenous injection of mesna at a dose of 20% (w/w) of the oxazaphosphorine dose, oral mesna (40% w/w) should be administered at 2 hours and again at 6 hours after the initial intravenous dose. Alternatively, three oral doses of mesna may be administered, replacing the i.v. dose …
WebOxazaphosphorine metabolism and transport have a major impact on pharmacokinetic variability, pharmacokinetic-pharmacodynamic relationship, toxicity, resistance, and drug … WebApr 1, 2012 · Oxazaphosphorines, with the most representative members including cyclophosphamide, ifosfamide, and trofosfamide, constitute a class of alkylating agents …
WebOxazaphosphorine resistance, together with dose-limiting toxicity (mainly neutropenia and neurotoxicity), significantly hinders chemotherapy in patients, and hence, there is …
WebIf the oxazaphosphorine dose is adjusted, the mesna dose should also be modified to maintain the mesna-to-oxazaphosphorine drug ratio. IV Bolus: 20% of the oxazaphosphorine dose at 0 hr, 4 hrs and 8 hrs Oral: 20% IV at 0 hr, 40% p.o … darvaza band tourWebOxazaphosphorine metabolism and transport have a major impact on pharmacokinetic variability, pharmacokinetic-pharmacodynamic relationship, toxicity, resistance, and drug … darvi groupWebNov 10, 2024 · Mesna (sodium 2-mercaptoethane sulfonate) is a detoxifying agent used to prevent hemorrhagic cystitis in patients receiving chemotherapy with either high-dose cyclophosphamide or ifosfamide. darvaza crater google mapshttp://www.bccancer.bc.ca/chemotherapy-protocols-site/Documents/Supportive%20Care/SCMESNA_Protocol.pdf darvaza crater wikiWebCyclophosphamide Synonyms: Cyclophosphamide monohydrate, 2- [Bis (2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide, Cytoxan Empirical Formula (Hill Notation): C7H15Cl2N2O2P · H2O CAS Number: 6055-19-2 Molecular Weight: 279.10 Product Comparison Guide Use the product attributes below to configure the … darvazaWeb3. Use MESNA infusion: MESNA dose equal to 20% of oxazaphosphorine dose y-sited to oxazaphosphorine over time of infusion. Then MESNA dose equal to 10% of oxazaphosphorine dose every hour to complete 24 hours of treatment day. (e.g., 30 to 60 minutes for etoposide or DOXOrubicin plus 2 hours of oxazaphosphorine infusion followed darvaza crater\u0027sWebIntratumoral Injection of Encapsulated Cells Producing an Oxazaphosphorine Activating Cytochrome P450 for Targeted Chemotherapy. In: Walden, P., Trefzer, U., Sterry, W., … b/b 19.52 matera